Stay updated on Augmenting TRD with Allopregnanolone Analog Clinical Trial
Sign up to get notified when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.

Latest updates to the Augmenting TRD with Allopregnanolone Analog Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page’s displayed site revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record now displays results for the ganaxolone trial, including participant flow, baseline characteristics, the Week 8 depression-scale outcome, and adverse-event data.SummaryDifference41%

- Check21 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide notice announces an NIH website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error instead of study results.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study results.SummaryDifference0.2%

Stay in the know with updates to Augmenting TRD with Allopregnanolone Analog Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Augmenting TRD with Allopregnanolone Analog Clinical Trial page.